These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 3734464

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fatal Stevens-Johnson syndrome associated with Fansidar and chloroquine.
    Lenox-Smith I.
    J Infect; 1987 Jan; 14(1):90-2. PubMed ID: 3819463
    [No Abstract] [Full Text] [Related]

  • 3. An unusual combination of phototoxicity and Stevens-Johnson syndrome due to antimalarial therapy.
    Ortel B, Sivayathorn A, Hönigsmann H.
    Dermatologica; 1989 Jan; 178(1):39-42. PubMed ID: 2917679
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis.
    Hellgren U, Rombo L, Berg B, Carlson J, Wiholm BE.
    Br Med J (Clin Res Ed); 1987 Aug 08; 295(6594):365-6. PubMed ID: 2958104
    [No Abstract] [Full Text] [Related]

  • 9. Fansidar-induced Stevens-Johnson Syndrome.
    Hornstein OP, Ruprecht KW.
    N Engl J Med; 1982 Dec 09; 307(24):1529-30. PubMed ID: 7144829
    [No Abstract] [Full Text] [Related]

  • 10. Stevens-Johnson syndrome due to pyrimethamine/sulfadoxine during presumptive self-therapy of malaria.
    Phillips-Howard PA, Behrens RH, Dunlop J.
    Lancet; 1989 Sep 30; 2(8666):803-4. PubMed ID: 2571042
    [No Abstract] [Full Text] [Related]

  • 11. Leads from the MMWR. Fansidar-associated fatal reaction in an HIV-infected man.
    JAMA; 1988 Oct 21; 260(15):2193. PubMed ID: 3262778
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii.
    Pearson RD, Hewlett EL.
    Ann Intern Med; 1987 May 21; 106(5):714-8. PubMed ID: 3551713
    [Abstract] [Full Text] [Related]

  • 14. Transient lupus anticoagulant and fansidar therapy.
    Jeffrey RF.
    Postgrad Med J; 1986 Sep 21; 62(731):893-4. PubMed ID: 3101054
    [Abstract] [Full Text] [Related]

  • 15. Does chloroquine contribute to the risk of serious adverse reactions to fansidar?
    Rombo L, Stenbeck J, Lobel HO, Campbell CC, Papaioanou M, Miller KD.
    Lancet; 1985 Dec 07; 2(8467):1298-9. PubMed ID: 2866354
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Boxed warning added to Fansidar labeling.
    FDA Drug Bull; 1985 Aug 07; 15(2):21. PubMed ID: 4054454
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.